Marshall Wace’s iShares US Healthcare ETF IYH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
+42,584
New +$2.66M ﹤0.01% 1651
2026
Q1
Sell
-120,459
Closed -$7.84M 3460
2025
Q4
$7.84M Buy
+120,459
New +$7.6M 0.01% 962
2024
Q4
Sell
-12,969
Closed -$843K 2790
2024
Q3
$843K Buy
12,969
+482
+4% +$30.8K ﹤0.01% 1716
2024
Q2
$765K Buy
+12,487
New +$751K ﹤0.01% 1797
2023
Q4
Sell
-8,270
Closed -$447K 2388
2023
Q3
$447K Buy
+8,270
New +$462K ﹤0.01% 1757
2023
Q1
Sell
-7,500
Closed -$426K 2882
2022
Q4
$426K Buy
+7,500
New +$414K ﹤0.01% 2431
2022
Q1
Sell
-13,500
Closed -$811K 3668
2021
Q4
$811K Buy
13,500
+6,000
+80% +$343K ﹤0.01% 2570
2021
Q3
$414K Buy
+7,500
New +$429K ﹤0.01% 2490
2019
Q4
Sell
-8,000
Closed -$302K 1891
2019
Q3
$302K Buy
+8,000
New +$308K ﹤0.01% 1199

Other funds holding IYH

Marshall Wace's IYH Position: Q2 2026 in Review

Marshall Wace opened a new position in iShares US Healthcare ETF (IYH) in Q2 2026: 42,584 shares worth $2.85M. The stake represents ﹤0.01% of the portfolio and ranks #1651 among its holdings. This is a return to the name: Marshall Wace previously reported a position in IYH as recently as Q4 2025.

Marshall Wace first reported a position in IYH in Q3 2019 and has held it in 9 quarters since. The position peaked at $7.84M in Q4 2025. 529 funds tracked by Wall St. Rank hold IYH as of Q2 2026.

  • Marshall Wace held 42,584 shares of iShares US Healthcare ETF worth $2.85M as of Q2 2026.
  • iShares US Healthcare ETF was a new Marshall Wace position in Q2 2026.
  • iShares US Healthcare ETF made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1651 holding.
  • Marshall Wace first reported a position in iShares US Healthcare ETF in Q3 2019 and has held it in 9 quarters since.
  • Marshall Wace's iShares US Healthcare ETF position peaked at $7.84M in Q4 2025.
  • 529 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.